Teva, Forest Settle Patent Fight Over $759M Namenda XR
A 2½-year patent battle over Forest Laboratories Inc.'s Alzheimer's drug Namenda XR ended in a settlement late Friday, just ahead of a planned five-day trial on federal infringement claims filed in...To view the full article, register now.
Already a subscriber? Click here to view full article